Creutzfeldt-Jakob disease epidemiology and demographics

Revision as of 14:04, 22 October 2018 by M Jahan (talk | contribs)
Jump to navigation Jump to search

Creutzfeldt-Jakob disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Creutzfeldt-Jakob disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Creutzfeldt-Jakob disease epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Creutzfeldt-Jakob disease epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Creutzfeldt-Jakob disease epidemiology and demographics

CDC on Creutzfeldt-Jakob disease epidemiology and demographics

Creutzfeldt-Jakob disease epidemiology and demographics in the news

Blogs on Creutzfeldt-Jakob disease epidemiology and demographics

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Creutzfeldt-Jakob disease epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Creutzfeldt-Jakob disease is a rare disorder with an incidence of approximately 0.1 to 0.3 cases per 100,000 individuals. In the USA, less than 300 cases of Creutzfeldt-Jakob disease have been reported. Individuals > 50 years of age are at higher risk of developing Creutzfeldt-Jakob disease than younger individuals. The most common age at diagnosis is approximately 60-65 years (range 45-90). On the other hand, variant (non-classic) Creutzfeldt-Jakob disease is more common among younger individuals. There is no gender or racial predilection for the development of Creutzfeldt-Jakob disease. Creutzfeldt-Jakob disease is more commonly described in Africa, but this is thought to be attributed to cannibalism practices in certain African tribes in the 1950s and ingestion of infected human brains, rather than true racial variation.

Epidemiology and Demographics

Incidence

  • Creutzfeldt Jakob disease is a very rare disorder
  • The incidence of Creutzfeldt Jakob disease is approximately 0.1 to 0.3 cases per 100,000 individuals.
  • In the USA, less than 300 cases of Creutzfeldt Jakob disease have been reported.

CJD deaths and age-adjusted death rate, USA, 1979-2004

Age

  • Individuals > 50 years of age are at higher risk of developing Creutzfeldt Jakob disease than younger individuals.
  • The most common age at diagnosis is approximately 60-65 years (range 45-90).
  • On the other hand, variant (non-classic) Creutzfeldt Jakob disease is more common among younger individuals.

Gender

  • There is no gender predilection for the development of Creutzfeldt Jakob disease.

Race

  • There is no racial predilection for the development of Creutzfeldt Jakob disease.
  • Creutzfeldt Jakob disease is more commonly described in Africa, but this is thought to be attributed to cannibalism practices in certain African tribes in the 1950s and ingestion of infected human brains, rather than true racial variation.

References


Template:WikiDoc Sources